Ana Sol Peinetti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ana Sol Peinetti has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Battaglini
INQUIMAE (CONICET), Departamento de Química Inorgánica, Analítica y Química Física, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, C1428EHA Buenos Aires, Argentina
6 shared publications - Daiana Andrea Capdevila
Fundacion Instituto Leloir
4 shared publications Graciela A. González
INQUIMAE (CONICET), Departamento de Química Inorgánica, Analítica y Química Física, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Pabellón 2, C1428EHA Buenos Aires, Argentina
4 shared publications- Yi Lu
Department of Chemistry University of Texas at Austin Austin Texas USA
4 shared publications - Graciela Alicia Gonzalez
Universidad de Buenos Aires (UBA)
3 shared publications - Omar Azzaroni
Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas, Argentina
3 shared publications
Latest Publications
- Open Access
In vitro evolution of DNA operators enables multivalency protein−DNA interactions: towards programmable transcription factor regulation
In vitro transcription (IVT) systems regulated by allosteric transcription factors (aTFs) are central to emerging cell-free biosensing and synthetic biology platforms, yet their performance is often limited by suboptimal protein–DNA interactions and the need for well-characterized regulatory elements. Here, we report an in vitro evolution strategy to engineer DNA operator sequences that enables tunable aTF–DNA interactions without requiring prior detailed knowledge of the native operator or regulatory mechanism. Using a SELEX-based approach with integrated positive and counter-selection steps, we evolved non-natural operators for the sulfane sulfur–responsive transcriptional repressor SqrR. The selected sequences preserve ligand-responsive allostery, with some sequences exhibiting enhanced binding affinity and reducing transcriptional leakage. Notably, we identify operator with binding behaviors consistent with cooperative recruitment of multiple SqrR dimers, suggesting that sequence architecture can modulate aTF–DNA interactions beyond affinity alone. Incorporation of these operators into IVT circuits improves transcriptional control and dynamic range, enabling the development of ROSALIND-based sensors for sulfane sulfur species, achieving sensitive and selective detection in a fully cell-free format. More broadly, this work establishes operator evolution as a programmable strategy to optimize transcription factor–DNA interactions and expand the design space of transcription-based biosensors, including for systems lacking well-characterized genetic components.
Open AccessIn vitro evolution of DNA operators enables multivalency protein−DNA interactions: towards programmable transcription factor regulation
In vitro transcription (IVT) systems regulated by allosteric transcription factors (aTFs) are central to emerging cell-free biosensing and synthetic biology platforms, yet their performance is often limited by suboptimal protein–DNA interactions and the need for well-characterized regulatory elements. Here, we report an in vitro evolution strategy to engineer DNA operator sequences that enables tunable aTF–DNA interactions without requiring prior detailed knowledge of the native operator or regulatory mechanism. Using a SELEX-based approach with integrated positive and counter-selection steps, we evolved non-natural operators for the sulfane sulfur–responsive transcriptional repressor SqrR. The selected sequences preserve ligand-responsive allostery, with some sequences exhibiting enhanced binding affinity and reducing transcriptional leakage. Notably, we identify operator with binding behaviors consistent with cooperative recruitment of multiple SqrR dimers, suggesting that sequence architecture can modulate aTF–DNA interactions beyond affinity alone. Incorporation of these operators into IVT circuits improves transcriptional control and dynamic range, enabling the development of ROSALIND-based sensors for sulfane sulfur species, achieving sensitive and selective detection in a fully cell-free format. More broadly, this work establishes operator evolution as a programmable strategy to optimize transcription factor–DNA interactions and expand the design space of transcription-based biosensors, including for systems lacking well-characterized genetic components.
- 9 January 2026
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 452
Single nanochannel-based iontronic detection of adenosine
- 9 January 2026
- Published by Elsevier in Sensors and Actuators B: Chemical
- Vol. 452
Single nanochannel-based iontronic detection of adenosine
- 23 October 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 293, 118147
Lateral flow cell-free transcriptional assay for contaminant detection
- 23 October 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 293, 118147
Lateral flow cell-free transcriptional assay for contaminant detection
- Open Access
Lateral flow cell-free transcriptional assay for contaminant detection
Cell free transcriptional biosensors are emerging as a powerful technology, offering enhanced capabilities for detecting chemical contaminants in settings where traditional analytical techniques fall short of societal needs. However, the sensitivity of these biosensors for many critical chemical contaminants often remains insufficient to meet regulatory detection limits, while maintaining portability and ensuring selectivity. In this work, an in vitro transcription (IVT) based lateral flow assay (LFA) is reported, which is 1000 times more sensitive than reported IVT portable detection methods. Through combining the amplification power of IVT with nucleic acid LFA-based avidity effects, we develop rapid, ultra-sensitive turn-on sensors. Our sensors meet regulatory detection limits for lead, a particularly challenging metal ion contaminant, in untreated spring water samples collected from a basin that exemplifies the environmental monitoring challenges. Additionally, we show that by optimizing the IVT conditions, we can tune the limit of detection to produce an on-off signal reaching the WHO regulation threshold and others. Finally, we evaluate the selectivity of different metal-responsive repressors in the context of in vitro biosensing and discuss how to identify potentially hazardous samples with an easy-to-use and point-of-care assay.
Open AccessLateral flow cell-free transcriptional assay for contaminant detection
Cell free transcriptional biosensors are emerging as a powerful technology, offering enhanced capabilities for detecting chemical contaminants in settings where traditional analytical techniques fall short of societal needs. However, the sensitivity of these biosensors for many critical chemical contaminants often remains insufficient to meet regulatory detection limits, while maintaining portability and ensuring selectivity. In this work, an in vitro transcription (IVT) based lateral flow assay (LFA) is reported, which is 1000 times more sensitive than reported IVT portable detection methods. Through combining the amplification power of IVT with nucleic acid LFA-based avidity effects, we develop rapid, ultra-sensitive turn-on sensors. Our sensors meet regulatory detection limits for lead, a particularly challenging metal ion contaminant, in untreated spring water samples collected from a basin that exemplifies the environmental monitoring challenges. Additionally, we show that by optimizing the IVT conditions, we can tune the limit of detection to produce an on-off signal reaching the WHO regulation threshold and others. Finally, we evaluate the selectivity of different metal-responsive repressors in the context of in vitro biosensing and discuss how to identify potentially hazardous samples with an easy-to-use and point-of-care assay.
- 31 December 2024
- Published by Springer Nature
- p. 213-244
Nucleic Acids Production
- 2 December 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (4) , 697-700
Harnessing concerted functions in confined environments: cascading enzymatic reactions in nanofluidic biosensors for sensitive detection of arginine
Cascading enzymatic reactions within nanochannels enable rapid (<5 min) and highly sensitive detection of arginine by leveraging cooperative functions in a confined environment.
- 2 December 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (4) , 697-700
Harnessing concerted functions in confined environments: cascading enzymatic reactions in nanofluidic biosensors for sensitive detection of arginine
Cascading enzymatic reactions within nanochannels enable rapid (<5 min) and highly sensitive detection of arginine by leveraging cooperative functions in a confined environment.
- Open Access
- 27 August 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (9) , 416
Overcoming Limited Access to Virus Infection Rapid Testing: Development of a Lateral Flow Test for SARS-CoV-2 with Locally Available Resources
The COVID-19 pandemic highlighted testing inequities in developing countries. Lack of lateral flow test (LFT) manufacturing capacity was a major COVID-19 response bottleneck in low- and middle-income regions. Here we report the development of an open-access LFT for SARS-CoV-2 detection comparable to commercial tests that requires only locally available supplies. The main critical resource is a locally developed horse polyclonal antibody (pAb) whose sensitivity and selectivity are greatly enhanced by affinity purification. We demonstrate that these Abs can perform similarly to commercial monoclonal antibodies (mAbs), as well as mAbs and other pAbs developed against the same antigen. We report a workflow for test optimization using nasopharyngeal swabs collected for RT-qPCR, spiked with the inactivated virus to determine analytical performance characteristics as the limit of detection, among others. Our final prototype showed a performance similar to available tests (sensitivity of 83.3% compared to RT-qPCR, and 90.9% compared to commercial antigen tests). Finally, we discuss the possibility and the challenges of utilizing affinity-purified pAbs as an alternative for the local development of antigen tests in an outbreak context and as a tool to address inequalities in access to rapid tests.
- 27 August 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (9) , 416
Open AccessOvercoming Limited Access to Virus Infection Rapid Testing: Development of a Lateral Flow Test for SARS-CoV-2 with Locally Available Resources
The COVID-19 pandemic highlighted testing inequities in developing countries. Lack of lateral flow test (LFT) manufacturing capacity was a major COVID-19 response bottleneck in low- and middle-income regions. Here we report the development of an open-access LFT for SARS-CoV-2 detection comparable to commercial tests that requires only locally available supplies. The main critical resource is a locally developed horse polyclonal antibody (pAb) whose sensitivity and selectivity are greatly enhanced by affinity purification. We demonstrate that these Abs can perform similarly to commercial monoclonal antibodies (mAbs), as well as mAbs and other pAbs developed against the same antigen. We report a workflow for test optimization using nasopharyngeal swabs collected for RT-qPCR, spiked with the inactivated virus to determine analytical performance characteristics as the limit of detection, among others. Our final prototype showed a performance similar to available tests (sensitivity of 83.3% compared to RT-qPCR, and 90.9% compared to commercial antigen tests). Finally, we discuss the possibility and the challenges of utilizing affinity-purified pAbs as an alternative for the local development of antigen tests in an outbreak context and as a tool to address inequalities in access to rapid tests.
- 4 November 2022
- Published by Bio-Protocol, LLC in Bio-Protocol
- Vol. 12 (21) , e4548
Binding Affinity Measurements Between DNA Aptamers and their Virus Targets Using ELONA and MST
Aptamers have been selected with strong affinity and high selectivity for a wide range of targets, as recently highlighted by the development of aptamer-based sensors that can differentiate infectious from non-infectious viruses, including human adenovirus and SARS-CoV-2. Accurate determination of the binding affinity between the DNA aptamers and their viral targets is the first step to understanding the molecular recognition of viral particles and the potential uses of aptamers in various diagnostics and therapeutic applications. Here, we describe protocols to obtain the binding curve of the DNA aptamers to SARS-CoV-2 using Enzyme-Linked Oligonucleotide Assay (ELONA) and MicroScale Thermophoresis (MST). These methods allow for the determination of the binding affinity of the aptamer to the infectious SARS-CoV-2 and the selectivity of this aptamer against the same SARS-CoV-2 that has been rendered non-infectious by UV inactivation, and other viruses. Compared to other techniques like Electrophoretic Mobility Shift Assay (EMSA), Surface Plasmon Resonance (SPR), and Isothermal Titration Calorimetry (ITC), these methods have advantages for working with larger particles like viruses and with samples that require biosafety level 2 facilities.
- 4 November 2022
- Published by Bio-Protocol, LLC in Bio-Protocol
- Vol. 12 (21) , e4548
Binding Affinity Measurements Between DNA Aptamers and their Virus Targets Using ELONA and MST
Aptamers have been selected with strong affinity and high selectivity for a wide range of targets, as recently highlighted by the development of aptamer-based sensors that can differentiate infectious from non-infectious viruses, including human adenovirus and SARS-CoV-2. Accurate determination of the binding affinity between the DNA aptamers and their viral targets is the first step to understanding the molecular recognition of viral particles and the potential uses of aptamers in various diagnostics and therapeutic applications. Here, we describe protocols to obtain the binding curve of the DNA aptamers to SARS-CoV-2 using Enzyme-Linked Oligonucleotide Assay (ELONA) and MicroScale Thermophoresis (MST). These methods allow for the determination of the binding affinity of the aptamer to the infectious SARS-CoV-2 and the selectivity of this aptamer against the same SARS-CoV-2 that has been rendered non-infectious by UV inactivation, and other viruses. Compared to other techniques like Electrophoretic Mobility Shift Assay (EMSA), Surface Plasmon Resonance (SPR), and Isothermal Titration Calorimetry (ITC), these methods have advantages for working with larger particles like viruses and with samples that require biosafety level 2 facilities.
- 7 September 2022
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 187,p. e64127
In vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
Virus infections have a major impact on society; most methods of detection have difficulties in determining whether a detected virus is infectious, causing delays in treatment and further spread of the virus. Developing new sensors that can inform on the infectability of clinical or environmental samples will meet this unmet challenge. However, very few methods can obtain sensing molecules that can recognize an intact infectious virus and differentiate it from the same virus that has been rendered non-infectious by disinfection methods. Here, we describe a protocol to select aptamers that can distinguish infectious viruses vs non-infectious viruses using systematic evolution of ligands by exponential enrichment (SELEX). We take advantage of two features of SELEX. First, SELEX can be tailor-made to remove competing targets, such as non-infectious viruses or other similar viruses, using counter selection. Additionally, the whole virus can be used as the target for SELEX, instead of, for example, a viral surface protein. Whole virus SELEX allows for the selection of aptamers that bind specifically to the native state of the virus, without the need to disrupt of the virus. This method thus allows recognition agents to be obtained based on functional differences in the surface of pathogens, which do not need to be known in advance.
- 7 September 2022
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 187,p. e64127
In vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
Virus infections have a major impact on society; most methods of detection have difficulties in determining whether a detected virus is infectious, causing delays in treatment and further spread of the virus. Developing new sensors that can inform on the infectability of clinical or environmental samples will meet this unmet challenge. However, very few methods can obtain sensing molecules that can recognize an intact infectious virus and differentiate it from the same virus that has been rendered non-infectious by disinfection methods. Here, we describe a protocol to select aptamers that can distinguish infectious viruses vs non-infectious viruses using systematic evolution of ligands by exponential enrichment (SELEX). We take advantage of two features of SELEX. First, SELEX can be tailor-made to remove competing targets, such as non-infectious viruses or other similar viruses, using counter selection. Additionally, the whole virus can be used as the target for SELEX, instead of, for example, a viral surface protein. Whole virus SELEX allows for the selection of aptamers that bind specifically to the native state of the virus, without the need to disrupt of the virus. This method thus allows recognition agents to be obtained based on functional differences in the surface of pathogens, which do not need to be known in advance.
- 20 December 2021
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (4) , 1498-1502
Label-Free Digital Detection of Intact Virions by Enhanced Scattering Microscopy
Several applications in health diagnostics, food, safety, and environmental monitoring require rapid, simple, selective, and quantitatively accurate viral load monitoring. Here, we introduce the first label-free biosensing method that rapidly detects and quantifies intact virus in human saliva with single-virion resolution. Using pseudotype SARS-CoV-2 as a representative target, we immobilize aptamers with the ability to differentiate active from inactive virions on a photonic crystal, where the virions are captured through affinity with the spike protein displayed on the outer surface. Once captured, the intrinsic scattering of the virions is amplified and detected through interferometric imaging. Our approach analyzes the motion trajectory of each captured virion, enabling highly selective recognition against nontarget virions, while providing a limit of detection of 1 × 103 copies/mL at room temperature. The approach offers an alternative to enzymatic amplification assays for point-of-collection diagnostics.
- 20 December 2021
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 144 (4) , 1498-1502
Label-Free Digital Detection of Intact Virions by Enhanced Scattering Microscopy
Several applications in health diagnostics, food, safety, and environmental monitoring require rapid, simple, selective, and quantitatively accurate viral load monitoring. Here, we introduce the first label-free biosensing method that rapidly detects and quantifies intact virus in human saliva with single-virion resolution. Using pseudotype SARS-CoV-2 as a representative target, we immobilize aptamers with the ability to differentiate active from inactive virions on a photonic crystal, where the virions are captured through affinity with the spike protein displayed on the outer surface. Once captured, the intrinsic scattering of the virions is amplified and detected through interferometric imaging. Our approach analyzes the motion trajectory of each captured virion, enabling highly selective recognition against nontarget virions, while providing a limit of detection of 1 × 103 copies/mL at room temperature. The approach offers an alternative to enzymatic amplification assays for point-of-collection diagnostics.